EMA Authorised: Sondelbay (teriparatide) — Accord Healthcare S.L.U.

View source ↗

Summary

EMA authorised Sondelbay (teriparatide) by Accord Healthcare S.L.U. for osteoporosis, marking EU marketing authorisation. Decision date: 23/03/2026.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Sondelbay (teriparatide)

Snippet

Status: Authorised. Therapeutic area: Osteoporosis. MAH: Accord Healthcare S.L.U.. Decision date: 23/03/2026